4,393 trials (keyword fallback)
Uterine Atony With Hemorrhage
Primary: Number of Participants With Need for Additional Uterotonics (Methylergonovine, Carboprost, Misoprostol) — 80; 80 Participants
Postpartum Period
Primary: Mirena in Place — 10; 3 participants
Pain
Primary: Number of Subjects Who Achieved 50% Sustained Pain Reduction — 0; 0; 2; 6 # of subjects with 50% pain reduction
Intraventricular Hemorrhage
Primary: Participants With Modified Rankin Scale (mRS) <=3 - Dichotomized Analysis — 47.6; 44.9 percentage of participants — p=0.554
Weight Loss · Diet Modification · Physical Activity
Primary: Recruitment — 163; 105; 195; 65 Participants
Viral Hepatitis B · Contraception · Breast Feeding, Exclusive
Primary: Utilization of Postpartum Contraception — 199; 213 participants — p=<0.05
Intravitreal Bevacizumab Injection · Pars Plana Vitrectomy · Tractional Retinal Detachment
Primary: Best Corrected Visual Acuity — 1.1; 1.4 LogMar
Intracerebral Hemorrhage · Acute Ischemic Stroke
Primary: Change in Interleukin-1beta Level in Blood (Picogram/Milliliter)
Intracerebral Hemorrhage
Primary: Number of Study Subjects With Life-threatening Thromboembolic Complications — 1; 0; 0 Participants — p=1.00
Influenza
Primary: Number of Participants Reporting Serious Adverse Events (SAEs) — 1; 0; 2; 1 participants
Diabetes, Gestational · Gestational Weight Gain · Postpartum Weight Retention
Primary: Number of Meals Successfully Ordered and Delivered — 2880 meals
Infection
Primary: Endometritis and Wound Infection — 6; 4 patients infected
Back Pain · Epidural Analgesia, Obstetric
Primary: Epidural Pressure Sensitivity at Level of Epidural Insertion — 26.8; 26.8; 47.6 force (newtons/cm^2)
Anemia
Primary: Evaluate the Safety of the Maximum Administered Dose, 15 mg/kg (up to a Maximum 1,000 mg) of FCM Compared to SMC. — 6; 22 participants
Hypertension, Pregnancy-Induced · Pre-eclampsia
Primary: Difference in Systolic Blood Pressure (SBP) — 131.8; 132.0; 129.1; 129.1 mmHg